LGALS9 and rheumatoid arthritis: Another study showed that galectin-9 mRNA expression levels in peripheral blood mononuclear cells (PBMCs) were significantly lower in RA patients with moderate to high disease activity than those with low disease activity [104,119], implicating that galectin-9 may prevent the disease progression of RA.